Reedland Capital Partners
  • About
    • Debt Advisory Services
    • Institutional Equity Finance
  • Team
  • Strategic Advisor
  • Services
    • Debt Advisory Services
    • Institutional Equity Finance
  • Transactions
    • Representative Transactions
    • Debt Case Studies
  • News
  • Contact
  • Menu Menu

Avanir Pharma

April 26, 2017/by reedland

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png 0 0 reedland https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png reedland2017-04-26 11:27:032017-04-26 11:27:24Avanir Pharma

CONTACT

415.383.4700
415.383.4799 (Fax)
Contact Reedland

ADDRESS

30 Sunnyside Avenue
Mill Valley, CA 94941

NEWS

  • Rubicon Technologies Announces Completion of Final Key Strategic Finance Objective

CONNECT

Please see Weild & Co.’s Regulation Best Interest, Form CRS Disclosure Here.
Securities offered through Weild & Co., member FINRA|SIPC.
Copyright © 2023 Reedland Capital Partners. All rights reserved. Read disclaimer.
    Scroll to top